GlideLink, Inc. is a platform technology company developing drug delivery system (DDS) formulations for localized injection and systemic circulation. 

Vision
Setting a New Global Standard in Formulation Platform Biotechnology

Mission
Creating partner-ready technology packages for precise and scalable global licensing-out

►Upon simple mixing of PEG and αCD, the hydrophobic repeating segments of PEG spontaneously thread into the hydrophobic inner cavity of αCD, generating strong supramolecular interactions that drive physical self-assembly. We refer to this distinctive self-assembly principle as the "Glide-in" mechanism. 

►Glide-in HydroMatrix™ (GHM) is GlideLink’s proprietary locally injectable platform for localized drug delivery. It is being developed to provide key technological advantages such as local injectability, drug-loading capability, controlled release, biodegradability, and tunable viscoelastic properties. Further technical details can be shared upon request in a confidential setting under CDA/NDA. 

►The GPP-T Series is GlideLink’s proprietary systemic circulation platform for APIs with extracellular mechanisms of action. It is being developed to provide key formulation advantages, including improved systemic exposure, pharmacokinetic optimization, and enhanced developability. Further technical details can be shared upon request in a confidential setting under CDA/NDA. 

►Tier 1. The IMD Group comprises OcuHydra-CS™, a prescription therapy for dry eye disease; OcuThera-V™, a depot-based glaucoma treatment; and Inflexa™, a therapeutic for arthritis pain relief. All three IMD assets are based on the shared GHM platform.

►Tier 2. The GPP-T Series is a systemic drug formulation platform built on next-generation PEGylation 2.0 technology for APIs with extracellular mechanisms of action.

►Both platform technologies are designed to advance rapidly through the pre-FIH stage, with a development roadmap focused on early-stage licensing-out and technology transfer.

• Head Office: #204, Building V1, KIST, 5 Hwarang-ro 14-gil, Seongbuk-gu, Seoul, Republic of Korea

• Business Registration No. 611-81-30865 

• Date of Incorporation: March 18, 2026 

• email: chryse@glide-in.com

• IR Biz Channel(KOR): http://pf.kakao.com/_JxdICX 

For further information on our development technologies, business activities, sector-specific partnerships, or IR materials, please contact GlideLink via email. 

TBD